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SUMMARY
The study group comprised 13 patients (mean age 68 years) with clinically fixed and biopsy
proven moderately differentiated rectal adenocarcinoma (8 high rectal, 5 low-mid rectal) who
receivedsynchronouscoursesofpreoperativecombinationchemotherapyandpelvicradiotherapy
(radiotherapy alone in 3 cases) over a period of8-20 weeks prior to surgical resection. All cases
showed varying degrees of mural and mesorectal fibrosis. Three cases did not differ otherwise
fromusual rectal adenocarcinoma while 4 had a 20-30% diminution in expected tumourarea. In
6 cases tumour could not be definitely identified grossly - 1 showed a 50% reduction in tumour
bulk while 5 had only residual microscopic foci from 0.6 - 4 mm in maximum dimensions. Only
3 cases had involvement of the mesorectal circumferential radial margin. Four involved lymph
nodes in 2 cases were partially hyalinised and calcified. Preoperative combination adjuvant
therapy can produce marked regressive morphological changes in rectal adenocarcinoma. The
implications ofthis are discussed.
INTRODUCTION
Early work by Papillon' illustrated the
preservative and curative potential of locally
applied irradiation in the treatment of limited
cancers of the rectum and anus. Stevens et a12
reportedthatpreoperativeradiotherapydecreased
local pelvic recurrence and increased 5 year
survival in 97 patients with recto-sigmoid
adenocarcinoma. Of these the tumour field was
sterilisedinninecasesandtherewereonlyresidual
microscopic foci in another three. Others have
notedpreoperativeradiotherapytogivedecreased
local recurrence rates3 7 (although this is not
universally accepted8), increased 5 year
survival,'3'7 improved resectability5 6 9 and
facilitation of local excision in medically unfit
patients.'0 Regression of disease in involved
lymph nodes producing "down staging" has also
been reported.3 4',7It appears that radiotherapy is
more effective when combined with
chemotherapy6 11 although there is some debate
as to whether preoperative or post operative
treatment is better.6 These potential benefits are
presumablyas aresultofregressioninthetumour
tissue induced by the adjuvant therapy.
Morphological aspects of this are described in
this paper.
METHODS
The 13 patients (9 male) aged between 48 and 84
years (mean 68) had biopsy proven rectal
adenocarcinoma (8 high rectum, 5 low-mid
rectum) and clinically fixed, tethered lesions (2
had evidence of liver metastases). In all cases
potential for curative surgical resection was
considered clinically to be either borderline or
notpossible. Afterdiagnosistheyreceivedpelvic
radiotherapy comprising 40 Gray in 20 fractions
over a period of 4 weeks. Three patients were
unfit for chemotherapy with one having had a
recent myocardial infarct. Three received
concomitant chemotherapy comprising folinic
acid with 5-Fluorouracil as a bolus and infusion
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over 48 hours12 as 2-3 cycles at 2 week intervals.
Theremaining patients had a5 day infusion of5-
Fluorouracil (1 gm/M2) during the first 5 days of
radiotherapy. Allproceededtooperativeresection
at 18-20 weeks after starting radiotherapy. The
resection specimens were opened, immersed in
10% formalin and fixed for 48 hours. Serial
transverse sections ofthetumour,bowelwall and
mesorectum were obtained according to Quirke
et all3 and any mesenteric lymph nodes sampled
(mean of 8 per case). The sections were stained
with haematoxylin and eosin formicroscopy and
tumour graded as well, moderately or poorly
differentiated. Two dimensional measurements
of the tumour and distances to the mesorectal
circumferential radial margin and serosa were
assessedgrosslyandverifiedusingthemicroscope
stage Vernier scale. An approximate estimate of
thepercentageofresidualtumourwasdetermined
from the gross and histological measurements;
these were assessed in combination with the
amountofreplacementfibrosisand/orgranulation
tissueseenalongtheexpectedtumourfrontwhich
was extrapolated between residual tumour foci.
Information onpre-treatmenttumourdimensions
for comparison against actual residual tumour
sizewasnotavailable. ADukes' stagewasderived
from the depth of invasion and the lymph node
status.
RESULTS
On biopsy and resection specimens the tumours
were all moderately differentiated rectal
adenocarcinoma, not otherwise specified. They
didnotshowanyde-differentiationintheresection
specimensandwereulceratedongrossinspection.
The maximum histological dimensions ranged
from 0.6 mm to 50 mm and distances to the
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Fig 1. An ulcer base of thickened, inflamed
fibromuscular connective tissue and a re-
epithelialised surface. No residual tumour.
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Fig 2. Case 1 Mesorectal reaction with residual
microscopic carcinoma (R), tumour necrosis (N)
and dystrophic calcification (C).
mesorectal circumferential radial margin 0 mm
to 25 mm (Table). All showed evidence ofmural
and mesorectal fibrous reaction and in 3 cases (2
receivednoconcurrentchemotherapy)thetumour
did not differ otherwise from usual
adenocarcinoma. In cases 1- 4, 7 and 13 tumour
could not be confidently identified on gross
examination-histologyin5 ofthesecasesshowed
anulcerbaseofthickened,inflamedfibromuscular
connectivetissuewithapartiallyre-epithelialised
surface(Figure 1).Thiswasduetotherapyinduced
regression inthe tumourtissue: case 3 showed an
approximate 50%reductionintumourbulkwhile
in cases 1, 2, 4, 7 and 13 carcinoma was only
identifiable microscopically (maximum
dimensions 0.6 - 4 mm). Residual foci were seen
in various layers of the bowel wall from the
submucosa to the mesorectum associated with
chronic inflammation, fibrosis, tumour necrosis
andcalcification (Figure 2). There were also foci
'"''m*
Fig 3. Residual submucosa tumour foci. The tumour
cells show bizarre nucleoli- and nucleomegalic
degenerative radiotherapy typechanges, necrosis
and apoptosis.
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of partially degenerate tumour acini encased in
an inflammatory and fibrous reaction with
constituent epithelium showing bizarre nucleolo
- and nucleomegalic degenerative radiotherapy
type changes, necrosis and apoptosis (Figure 3).
In addition 2 cases showed hyalinisation and
calcification in 4 involved lymph nodes.
Carcinoma involved (to within 1 mm) the
mesorectal circumferential radial margin of
resection in 3 cases.
The bowel adjacent to the tumours showed
variable degrees of low grade mucosal chronic
inflammation-presumablyradiotherapyrelated.
Some of the mesorectal vessels were also
thickened.
TABLE
Rectal Adenocarcinoma receiving preoperative adjuvant therapy
Case Gross (mm) Tumour Histology Stage Comment
Maximum Distance (mm)
Dimension from serosa (s),
(mm) deep Radial
Limit (1)
1 Ulcer 13 x 10 0.6 1 (s) C1 Tumour necrosis/calcification
15 (1)
2 Ulcer 30 x 30 4 2 (s) D Tumour gland atypia. Regressive changes in 2
20 (1) involved nodes
3 Ulcer 30 x 15 14 9 (1) C, 50% tumour viable. Regressive changes in 2
involved nodes
4 Ulcer 30 x 30 4 1 (s) B Healing ulcer
6 (1)
5 Ulcer 45 x 40 45 1 (1) C1 Tumour viable
6 Ulcer 50 x 30 50 5 (s) B Tumour viable
25(1)
7 Ulcer 40 x 30 1 8 (s) B 2 microscopic (1 mm) foci at muscular/mes
10 (1) orectumjunction
8 Ulcer 32 x 32 32 0 (1) c2 Tumour viable
9 Ulcer 37 x 30 27 2 (s) B 70-80% tumour viable
0 (1)
10 Ulcer 40 x 35 33 4 (s) B 70-75% tumour viable
7 (1)
11 Ulcer 40 x 30 25 15 (1) A 60-70% tumour viable
12 Ulcer 40 x 40 35 5 (s) D 80-90% tumour viable
15 (1)
13 Ulcer 8 x 8 2 3 (1) C2 2 microscopic (< 1 mm) foci at mucosa and
mesorectum
NOTE: Dukes' Stage
A = tumour confined to the wall
B = tumour through the wall
Cl = tumour in regional lymph nodes
C2 = tumour in the regional suture tie limit node
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DISCUSSION
This study demonstrates that preoperative
combination adjuvant therapy can potentially
produce marked morphological changes of
regression in the bowel wall involved by rectal
adenocarcinoma. Presumably this is the basis for
the suggestion that it results in improved 5 year
survival anddecreased localrecurrencerates2-7,11
and is therefore, currently, the subject of large,
standardised international trials. Tumour
regressionhasbeenpreviouslydescribedinrectal
adenocarcinoma receiving either preoperative
radiotherapy alone2'4 or in combination with
chemotherapy.9 These authors noted significant
changes in the majority of lesions with total or
sub-total regression in a minority. The effects
were more noticeable in Dukes A/B tumours but
particularly if they were exophytic, mobile and
well to moderately differentiated4 where a flat,
well demarcated ulcer with a re-epithelialised
surface resulted.9 The extent of residual tumour
couldnotbeassessedbyendoluminalultra-sound
or gross examination but only by microscopy
which showed viable, degenerate and necrotic
tumour associated with mucin pools. Adjuvant
therapy did not induce any de-differentiation in
the tumour and preoperative biopsy histology
could not reliably predict which tumours would
respond to treatment or give an accurate
determination ofstage ofdisease.9 Two issues of
practical importance have tentatively emerged.
Firstly, Marks et allo suggested that tumour
response to preoperative radiotherapy could
facilitate full thickness disc or hemi-
circumferential local excision in select patients
who were either not medically fit for radical
surgery, or, whereradical surgery offeredlimited
benefitsbutforwhomsphincterpreservation was
important. Thirteen of 14 patients retained good
sphincteric control and had three year actuarial
local recurrence and survival rates of 23% and
61% respectively. Similarly, others have noted
the benefit of sphincter preservation5' 6 and
improved local resectability.5' 69 The most
important indicator of local recurrence and
prognosis is involvement of the mesorectal
circumferential radial margin of resection'3 and
improvedclearancecanbeobtainedbymeticulous
surgical technique with excision of an intact
mesorectum.14HoweverSchaldenbrandeta19also
noted preoperative combination therapy to
improve resectability in 4 out of 13 clinically
fixed and tethered lesions. Furthermore 4 out of
C) The Ulster Medical Society, 1999.
6 cancers not resected for cure had no viable
residual tumour in the marginal mesorectal
fibrosis -it is ofnote that only 3 ofourclinically
fixed cases involved the circumferential radial
resection margin. Secondly, adjuvant therapy
diminishes the size and harvest of normal
mesorectallymphnodesbut, asinbreastcancer,15
can also induce regression in those involved by
tumour.4'9 In the present study 2 cases had 4
involved nodes which showed partial
hyalinisation and calcification. Horn eta14 noted
"down staging" of disease with lymph node
involvement in 18.4% ofirradiated cases versus
27.5% of controls. Overall prognosis was not
changed but they postulated a potential role for
preoperative treatment in transferring node
positive patients to a better prognostic category.
Others have also reported a decreased incidence
of involved nodes.3'7
Preoperative combination adjuvant therapy can
inducemarkedmorphologicalregressionofrectal
adenocarcinoma and possibly even involved
lymph nodes in some patients. This has obvious
implications for the pathologist in surgical
reporting. Surgeons submitting these specimens
shouldinformthe pathologist aboutpreoperative
adjuvanttherapy. It may also facilitate improved
local surgical resection - the biological
significanceofso-called"downstaging"requires
more extensive study. Further investigations
should also address why there is a spectrum of
complete, partial and non-response of rectal
carcinoma to neo-adjuvant therapy.
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